Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices By: CNBC.com News February 06, 2024 at 06:56 AM EST The quarterly results are the first to include sales of Eli Lilly's new weight loss drug Zepbound, which won FDA approval in early November. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices By: CNBC.com News February 06, 2024 at 06:56 AM EST The quarterly results are the first to include sales of Eli Lilly's new weight loss drug Zepbound, which won FDA approval in early November. Read More >>